Sunrise Medical, a global developer of assistive mobility solutions, has announced plans to list on the regulated market (Prime Standard) of the Frankfurt Stock Exchange in the summer of 2024, subject to market conditions. The offering will consist of private placements of newly issued shares from a capital increase as well as a secondary component from an existing shareholder, Cidron Liberty Systems, an entity controlled by Nordic Capital. In addition to any secondary proceeds, Sunrise Medical aims to raise €240m (US$260m) in gross proceeds from the private placement.
Proceeds will go towards repaying existing debt and strengthen its balance sheet, resulting in a reduction of leverage. The listing is expected to strengthen Sunrise Medical’s future growth potential and expand its financing opportunities. It has a strong pipeline and a clearly defined M&A strategy to complement its in-house innovation.
Sunrise Medical…
